HOME >> BIOLOGY >> NEWS
Celebrex may be safe for preterm labor, preliminary study finds

St. Louis, Sept. 23, 2002 -- The drug celecoxib may be a safer alternative for treating preterm labor than traditional therapies, according to a preliminary study led by Washington University School of Medicine in St. Louis. The study is published at the end of the month in the September issue of the American Journal of Obstetrics and Gynecology, and appears on the journal's website today.

One of the established treatments to prevent preterm delivery is indomethacin, a drug used to slow uterine contractions and delay delivery. But indomethacin is associated with severe side effects. Recent research suggests that celecoxib, also known as celebrex, may be a safer alternative. This study is the first clinical trial testing celecoxib in pregnant women.

"Celecoxib appears to be safer, particularly for the fetus," says Yoel Sadovsky, M.D., director of the Division of Genetics, Maternal-Fetal Medicine and Ultrasound at the School of Medicine. "These preliminary results also suggest that celecoxib is just as effective, and we are currently planning a larger trial to further examine its effectiveness."

The study was a combined effort between Washington University and Northwestern University. Sadovsky, also associate professor of obstetrics and gynecology and of cell biology and physiology, led the study. The first authors are Catherine S. Stika, M.D., at Northwestern University and Gilad A. Gross, M.D., assistant professor of obstetrics and gynecology at Washington University.

According to the American College of Obstetrics and Gynecology, about 1 in every 10 births in the United States occurs within the first 37 weeks of pregnancy and therefore is considered "preterm." Preterm labor is responsible for about 75 percent of newborn deaths not related to birth defects, and preterm infants often experience life-long complications.

Indomethacin, one of the standard drugs used to treat preterm labor, prevents the production of a type of p
'"/>

Contact: Gila Z. Reckess
reckessg@msnotes.wustl.edu
314-286-0109
Washington University School of Medicine
23-Sep-2002


Page: 1 2

Related biology news :

1. Case researchers substantiate bacterial link to preterm birth through mice studies
2. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
3. Preeclampsia linked with higher risk of preterm delivery
4. Preeclampsia linked with higher risk of preterm delivery and later-life vascular disease
5. Predicting preterm birth still nearly impossible, study in New England Journal finds
6. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
7. Two-drug approach might shorten painful labor, reduce Caesarean sections
8. Society report encourages preliminary sex analysis of clinical trial data
9. Contract bridge enhances the immune system, according to a preliminary study by researchers at UC Berkeley
10. Novel anti-cancer agent shows minimal side effects with preliminary evidence of tumor shrinkage
11. Student science contest participation influences study, career choices, alumni say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... ... collaboration with the National Research Council of Canada (NRC) to create the ... and lab-on-a-chip technologies and in manufacturing, LIFT will offer a competitive capacity ...
(Date:10/8/2019)... ... October 07, 2019 , ... Imaging data sets are ... as optical projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and ... sets inhouse, a lot of research groups struggle with transforming these large and ...
(Date:10/4/2019)... ... October 04, 2019 , ... Representatives with ... 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. , “To better connect ... said Miao Guo, Vice President of Operations and spokesperson for MyBioGate. , Guo ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... , ... October 02, 2019 , ... ... life sciences leadership firm that is enabling clinical program outsourcing success by cultivating ... by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... spectrometry, is pleased to announce that it has moved into a new, 5000 ... analytical instruments, the new facility demonstrates the company's continuous commitment to quality research ...
(Date:9/24/2019)... , ... September 24, 2019 ... ... presenting their latest research in the area of high-level X-ray methods using ... Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction and ...
(Date:9/24/2019)... POWAY, Calif. (PRWEB) , ... September 24, 2019 ... ... human adipose-derived stem cell company, has completed training and site qualification for clinical ... the process of recruitment and screening of potential clinical trial participants. , Clinical ...
Breaking Biology Technology:
Cached News: